|
OMIM |
Link |
Information gain |
01 |
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000325055
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000231816
|
|
|
CCR5
|
[NCBI]
|
0.000120257
|
|
|
TNF
|
[NCBI]
|
9.4485e-05
|
|
|
MDD
|
[NCBI]
|
8.85841e-05
|
|
|
SLE
|
[NCBI]
|
8.75596e-05
|
|
|
GC
|
[NCBI]
|
8.0777e-05
|
|
|
BL
|
[NCBI]
|
7.511e-05
|
|
|
PLSJ
|
[NCBI]
|
7.45508e-05
|
|
|
B2M
|
[NCBI]
|
7.03475e-05
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
6.82623e-05
|
|
|
KRT7
|
[NCBI]
|
6.42691e-05
|
|
|
KIR2DL2
|
[NCBI]
|
6.42691e-05
|
|
|
KIR2DL1
|
[NCBI]
|
5.90715e-05
|
|
|
KIR2DL3
|
[NCBI]
|
5.90715e-05
|
|
|
ERV1
|
[NCBI]
|
5.56975e-05
|
|
|
LIP
|
[NCBI]
|
5.28315e-05
|
|
|
CCL5
|
[NCBI]
|
5.11918e-05
|
|
|
PIAS1
|
[NCBI]
|
4.811e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
4.4468e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
4.30021e-05
|
|
|
ADA
|
[NCBI]
|
4.08776e-05
|
|
|
CXCR4
|
[NCBI]
|
4.03008e-05
|
|
|
CXCL12
|
[NCBI]
|
3.91709e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
3.60071e-05
|
|
|
HLA-A
|
[NCBI]
|
3.45738e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
2.93102e-05
|
|
|
CCL22
|
[NCBI]
|
2.85677e-05
|
|
|
IGFALS
|
[NCBI]
|
2.49104e-05
|
|
|
SERPINA6
|
[NCBI]
|
2.24727e-05
|
|
|
MUC1
|
[NCBI]
|
2.14503e-05
|
|
|
EPO
|
[NCBI]
|
1.57299e-05
|
|
|
TNFSF10
|
[NCBI]
|
1.52289e-05
|
|
|
IL2
|
[NCBI]
|
1.27788e-05
|
|
|
HP
|
[NCBI]
|
1.21703e-05
|
|
|
SLC6A3
|
[NCBI]
|
1.19776e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
6.61395e-06
|
|
|
SHBG
|
[NCBI]
|
6.55292e-06
|
|
|
AFP
|
[NCBI]
|
4.8533e-06
|
|
|
VDR
|
[NCBI]
|
4.84842e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
4.37974e-06
|
|
|
RNASE3
|
[NCBI]
|
4.27869e-06
|
|
|
VEGF
|
[NCBI]
|
2.01939e-06
|
|
|
TH
|
[NCBI]
|
1.912e-06
|
|
|
CEACAM5
|
[NCBI]
|
1.30112e-06
|
|
|
HGF
|
[NCBI]
|
1.11815e-06
|
|
|
NPY
|
[NCBI]
|
1.0335e-06
|
|
|
MBP
|
[NCBI]
|
9.81983e-07
|
|
|
GFAP
|
[NCBI]
|
1.21114e-07
|
|
|
PRL
|
[NCBI]
|
1.96402e-08
|
|